Stock SUVENPHAR SUVEN PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Suven Pharmaceuticals Limited Bombay S.E.

Equities

SUVENPHAR

INE03QK01018

Delayed Bombay S.E.
Other stock markets
 01:35:20 2024-06-26 EDT 		5-day change 1st Jan Change
731 INR +1.41% Intraday chart for Suven Pharmaceuticals Limited -0.63% +0.61%
06-19 Transcript : Sapala Organics Private Limited, Suven Pharmaceuticals Limited - M&A Call
06-14 Suven Pharmaceuticals to Acquire 67.5% Stake in Sapala Organics MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Sapala Organics Private Limited, Suven Pharmaceuticals Limited - M&A Call
Suven Pharmaceuticals to Acquire 67.5% Stake in Sapala Organics
MT
Suven Pharmaceuticals Limited agreed to acquire 67.50% stake in Sapala Organics Private Limited for INR 2.3 billion.
CI
Transcript : Suven Pharmaceuticals Limited, Q4 2024 Earnings Call, May 30, 2024
Suven Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Suven Pharmaceuticals Limited Announces Shifting of Registered Office
CI
Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call
Indian shares set to rise on strong domestic growth, in-line US inflation data
RE
Suven Pharmaceuticals Limited agreed to acquire Cohance Lifesciences Limited for INR 81,340.421103 million
CI
US FDA Clears Suven Pharmaceuticals' API and Formulations Plants in Hyderabad, India
MT
Suven Pharmaceuticals' Consolidated Net Profit Declines in Fiscal Q3
MT
Transcript : Suven Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 05, 2024
Suven Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Suven Pharmaceuticals CFO Steps Down
MT
Suven Pharmaceuticals Limited Announces CFO Changes, Effective January 2, 2024
CI
Suven Pharmaceuticals Names CFO
MT
Suven Pharmaceuticals Limited Appoints Dr. Vetukuri Venkata Naga Kali Vara Prasada Raju as Managing Director
CI
Suven Pharmaceuticals Limited Announces Board Appointments
CI
Suven Pharmaceuticals Limited Approves Interim Dividend for the Financial Year 2023-24
CI
Suven Pharmaceuticals Limited Proposes Interim Dividend for the Financial Year 2022-23
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SUVENPHAR Stock
  4. SUVENPHAR Stock
  5. News Suven Pharmaceuticals Limited